Victor Abramov
Global strategist at Samsung GSG (Global Strategy Group)- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English - fluent -
-
German Limited working proficiency
Topline Score
Bio
Credentials
-
End-to-End Machine Learning with TensorFlow on GCP
CourseraNov, 2020- Nov, 2024 -
SQL for Data Science
CourseraJul, 2020- Nov, 2024 -
Neural Networks and Deep Learning
CourseraMar, 2020- Nov, 2024
Experience
-
Samsung GSG (Global Strategy Group)
-
South Korea
-
Information Technology & Services
-
1 - 100 Employee
-
Global strategist
-
Mar 2021 - Present
-
-
-
INSEAD
-
Higher Education
-
700 & Above Employee
-
MBA Candidate 20D
-
Jan 2020 - Mar 2021
-
-
-
SENSTERIA
-
France
-
Computers and Electronics Manufacturing
-
Startup founders' advisor
-
Jun 2020 - Oct 2020
Developing a go-to-market strategy for a connected medical device aimed at helping people with musculoskeletal disorders.
-
-
-
Ipsen
-
France
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Project manager for strategic projects and research
-
Apr 2017 - Jan 2020
Ipsen is a fast growing global biotech company with focus on oncology, neurology and rare diseases. Key achievements: - Identified new portfolio development opportunities. Organized project teams, created and presented business cases on new products and SKU launches. Got green light for several projects, expected to increase 2023 sales by €15M - Developed and implemented KPI system centered on brand, so that every function can see its impact on achieving short- and long-term goals - Introduced process of regular business reviews for all functions (medical, marketing, market access, finance). one monthly meeting of just 90min length, saving more than 7 hours for each top manager - Optimized ongoing market researches, saving €500K annually. Increased business functions participation in research activities
-
-
-
IMS Health
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Experienced Consultant
-
Aug 2014 - Mar 2017
IMS Health Inc. (NYSE: IMS) is a global leader in pharmaceutical and healthcare market research and consulting services.IMS employs more than 3 000 consultants worldwide to provide both strategic and operational recommendations to Big Pharma companies.Key achievements: - Led project for optimizing sales force allocation of 1300 representatives across 130 cities and presented results to the client. Increased sales by €5M, client relations were improved, new subsequent projects started - Assumed overall project leadership for optimal pricing analysis for new SKUs and possible sales upside estimation. Oversaw a team of 3 analysts, did statistic modeling with price elasticity study and market analogues research. Realized increase in overall sales value by 15% for stagnating brand - Developed recommendations on the new drug launch model for local market - going alone VS outsourcing. Assumed overall project leadership, analyzed launch excellence database, lead client engagement. Client launched the drug with recommended partner, achieving big success on local market – drug reached €10M sales threshold in 1,5 years due to fast market access
-
-
-
Strategy Partners
-
Russian Federation
-
Business Consulting and Services
-
1 - 100 Employee
-
Consultant
-
Aug 2011 - Aug 2014
-
-
From Junior to Senior Analyst
-
Jan 2009 - Jul 2011
-
-
Intern
-
May 2008 - Jan 2009
-
-
Education
-
INSEAD
Master of Business Administration - MBA, Data science -
Higher School of Economics
bachelor degree, corporate finance